+772.1%
MRNA vs SMTC
+26.4%
+745.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SMTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -13.9% | +11.8% | -3.2% |
| 7D | -12.7% | -23.5% | +10.8% | -14.5% |
| 30D | -20.7% | -38.1% | +17.5% | -24.7% |
| 3M | +46.3% | -29.8% | +76.1% | +44.8% |
| 6M | +305.2% | -38.2% | +343.5% | +289.5% |
| YTD | +561.2% | +18.9% | +542.3% | +455.9% |
| 1Y | +772.1% | +40.1% | +732.0% | +602.9% |
| All | +772.1% | +26.4% | +745.7% | +602.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SMTC.
Daily Out/Under-Performance
Portfolio return minus SMTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SMTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SMTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling